The department used its new system for determining whether a condition is service-connected to give affected veterans access ...
Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Legend Biotech (LEGN – Research Report) and keeping the price ...
Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...
WIAT Birmingham on MSN1h
MMRF Multiple Myeloma Community Connect event to be held Nov. 14MMRF Multiple Myeloma Community Connect event to be held Nov. 14 ...
Nammi Therapeutics has commenced the first in-human Phase I trial of QXL138AM by dosing the first subject for treating ...
Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...
The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...
If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...
The different types of multiple myeloma (MM) are typical myeloma, light chain multiple myeloma (LCMM), nonsecretory myeloma (NSM), and IgM myeloma. Multiple myeloma (MM) is a type of blood and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback